CSIMarket
 
Clearpoint Neuro Inc   (NASDAQ: CLPT)
 
Price: $13.9600 $-0.09 -0.641%
Day's High: $14.085399627685547 Week Perf: -7.79 %
Day's Low: $ 13.77 30 Day Perf: -6.56 %
Volume (M): 384,792 52 Wk High: $ 30.10
Volume (M$): $ 0 52 Wk Avg: $14.73
Open: $14.00 52 Wk Low: $8.27



 Market Capitalization (Millions $) 412
 Shares Outstanding (Millions) 30
 Employees 172
 Revenues (TTM) (Millions $) 41
 Net Income (TTM) (Millions $) -29
 Cash Flow (TTM) (Millions $) 24
 Capital Exp. (TTM) (Millions $) 1

Business Description


Clearpoint Neuro Inc. is a medical technology company that focuses on developing and commercializing innovative solutions for neurosurgery and neurology. The company's main product is the ClearPoint Neuro Navigation System, a platform used to perform minimally invasive brain surgeries with real-time MRI guidance.

ClearPoint's system provides precise targeting and visualization during brain procedures, enabling surgeons to perform interventions with increased accuracy and safety. The company's technology is utilized in a range of neurosurgical applications such as biopsies, ablations, and electrode implantations for deep brain stimulation.

ClearPoint also offers a software suite called ClearTrace, which provides real-time monitoring and analysis of brain tissue during procedures. This software assists in optimizing therapeutic interventions and improves patient outcomes.

ClearPoint Neuro Inc. is dedicated to advancing the field of neurosurgery by improving patient care and facilitating the development of new therapies. They collaborate with leading medical centers, researchers, and technology companies to drive innovation and support the growth of the neurosurgical field.


   Company Address: 120 S. Sierra Ave. Solana Beach 92075 CA
   Company Phone Number: 287-9109   Stock Exchange / Ticker: NASDAQ CLPT


   

Stock Performances by Major Competitors

5 Days Decrease / Increase
     
BSX        2.05% 
EW   -0.34%    
ISRG   -1.58%    
MDT        3.22% 
SYK   -8.33%    
ZBH   -2.81%    
• View Complete Report
   



Management Announcement

ClearPoint Neuro Achieves Debt-Free Status with Early Repayment of $10 Million Note,

Published Mon, Aug 26 2024 8:06 PM UTC

ClearPoint Neuro Achieves Debt-Free Status with Early Repayment of $10 Million Note
ClearPoint Neuro, a leading therapeutic neuro-navigation system provider, has made a significant stride towards improving its financial health by announcing the early repayment of a $10 million convertible note, held by PTC Therapeutics. This repayment marks a pivotal moment for ClearPoin...

Partnership

ClearPoint Neuro Celebrates Milestone as Partner Aspen Neuroscience Implements ClearPoint Navigation System for ASPIR...

Published Thu, Jun 20 2024 12:45 PM UTC

ClearPoint Neuro, a global leader in intraoperative neurosurgical planning and navigation solutions, is pleased to announce a significant milestone achieved by its valued partner, Aspen Neuroscience. The renowned ClearPoint Navigation System will be utilized for all enrolled patients participating in Aspen s groundbreaking ASPIRO clinical trial. This trial aims to evaluate t...

Product Service News

ClearPoint Neuro, a leading provider of innovative medical devices for neurol...

Published Sat, Jun 1 2024 1:00 PM UTC

Rapid Advances in Neurosurgical Technology Drive Revenue Growth for ClearPoint Neuro Inc. ClearPoint Neuro, a leading provider of innovative medical devices for neurological procedures, recently announced the full market release of two groundbreaking technologies - the SmartFrame OR and the Prism Laser Therapy System. These products, designed to enhance precision and improve...

Product Service News

ClearPoint Neuro Makes Revolutionary Strides in Surgery and Drug Delivery: A Forecast of Anticipated Growth

Published Thu, May 2 2024 8:05 PM UTC

ClearPoint Neuro, Inc., a leading innovator in bio-navigational systems, has firmly positioned itself at the forefront of gene and cell therapy research with groundbreaking projects. Preeminent among these are novel drug delivery research and a pioneering stereotactic system. ClearPoint Neuro s insightful ventures, snaking through the 27th American Society of Gene & Cell The...

Product Service News

ClearPoint Neuro Makes Significant Strides in Neurological Treatments with FDA Approvals and Successful Clinical Trials

Published Mon, Apr 29 2024 12:01 PM UTC

ClearPoint Neuro, a health-tech company focusing on innovative neurological treatments and tools, recently gained the US Food and Drug Administration (FDA) clearance for its Prism Bone Anchor Accessory. This clearance implies that the Prism Neuro Laser Therapy will now have expanded usage within the operating room, signifying a significant development in intraoperative treat...




Fundamental Analysis

Valuation Current
Price to Earnings PE Ratio (TTM) -
Price to Earnings PE Ratio (Expected) -
Price to Sales (TTM) 10.16
Price to Sales (Expected) -
Price to Book 21.89
PEG (TTM) -

Financial Strength Current
Quick Ratio 3.75
Working Capital Ratio 5.79
Leverage Ratio (MRQ) 3.96
Total Debt to Equity 2.63
Interest Coverage (TTM) -
Debt Coverage (TTM) -

Per Share Current
Earnings (TTM) -1.01 $
Revenues (TTM) 1.37 $
Cash Flow (TTM) 0.82 $
Cash 1.2 $
Book Value 0.64 $
Dividend (TTM) 0 $

Efficiency Current
Revenue per Employee (TTM) 236,128
Net Income per Employee (TTM) -168,988
Receivable Turnover Ratio (TTM) 6.92
Inventory Turnover Ratio (TTM) 2.05
Asset Turnover Ratio (TTM) 0.52

Profitability Ratios Current
Gross Margin (MRQ) 63.95 %
Operating Margin (MRQ) -69.9 %
Net Margin (MRQ) -78.76 %
Net Cash Flow Margin (MRQ) -86.22 %
Effective Tax Rate (TTM) -

Management Effectiveness Current
Return On Assets (TTM) -
Return On Investment (TTM) -
Return On Equity (TTM) -
Dividend Yield -
Pay out Ratio (TTM) -



Clearpoint Neuro Inc's Segments
Biologics and drug delivery    39.64 % of total Revenue
Biologics and Drug Delivery - Disposable Products    15.63 % of total Revenue
Biologics and Drug Delivery - Services and License Fees    24.02 % of total Revenue
Neurosurgery navigation and therapy    48.54 % of total Revenue
Neurosurgery Navigation and Therapy - Disposable Products    48.54 % of total Revenue
Capital equipment and software    11.82 % of total Revenue
Capital Equipment and Software - Systems and Software Products    8.41 % of total Revenue
Capital Equipment and Software - Services    3.41 % of total Revenue
Capital Equipment and Software-Related Service    18.96 % of total Revenue

  Clearpoint Neuro Inc Outlook

On January 8 2024 the Clearpoint Neuro Inc provided following guidance

ClearPoint Neuro, Inc., a global therapy-enabling platform company that specializes in providing navigation and ...





Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.